Jerusalem Pharmaceuticals Company reported audited consolidated earnings results for the year 2013. For the year, the company reported net profit after taxes reached USD 2,248,123 compared with a net profit after taxes of USD 195,591 for 2012, a net increase of 1,049.4%.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.81 USD | -.--% | -.--% | +0.26% |
1st Jan change | Capi. | |
---|---|---|
+0.26% | 68.58M | |
+19.98% | 43.48B | |
+20.67% | 22.65B | |
+14.56% | 14.73B | |
+14.32% | 13.79B | |
+44.72% | 12.04B | |
-8.37% | 7.08B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+11.90% | 5.47B |
- Stock Market
- Equities
- JPH Stock
- News Jerusalem Pharmaceuticals Co. Ltd.
- Jerusalem Pharmaceuticals Company Reports Audited Consolidated Earnings Results for the Year 2013